-- Hebei Changshan Biochemical Pharmaceutical (SHE:300255) obtained a pharmaceutical registration certificate from Belarus' drug regulator for its dalteparin sodium injection, according to a Thursday disclosure on the Shenzhen bourse.
The drug is used to treat acute deep vein thrombosis and unstable coronary artery diseases.